For example, PIM2 modulates mTORC1 activity through phosphorylation of TSC2 in other cancers [21], while PIM1 phosphorylates PRAS40 thereby relieving its inhibitory effects on mTORC1 with a subsequent increase in mTORC1 activity [22]. This evidence concerns the gene PIM2 and cancer.